Perspective Therapeutics (CATX) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to $2.0 million.

  • Perspective Therapeutics' Interest & Investment Income fell 4535.05% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 1534.68%. This contributed to the annual value of $10.5 million for FY2024, which is 102580.3% up from last year.
  • Per Perspective Therapeutics' latest filing, its Interest & Investment Income stood at $2.0 million for Q3 2025, which was down 4535.05% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Interest & Investment Income registered a high of $3.6 million during Q3 2024, and its lowest value of $21000.0 during Q1 2021.
  • Its 5-year average for Interest & Investment Income is $1.0 million, with a median of $334000.0 in 2023.
  • Per our database at Business Quant, Perspective Therapeutics' Interest & Investment Income plummeted by 8894.83% in 2023 and then skyrocketed by 416935.48% in 2024.
  • Over the past 5 years, Perspective Therapeutics' Interest & Investment Income (Quarter) stood at $31000.0 in 2021, then soared by 1709.68% to $561000.0 in 2022, then tumbled by 88.95% to $62000.0 in 2023, then skyrocketed by 4169.35% to $2.6 million in 2024, then decreased by 26.07% to $2.0 million in 2025.
  • Its Interest & Investment Income was $2.0 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.4 million in Q1 2025.